Trial intelligence / Profile preview

INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV

PACTR201706002336105Recruiting

Sponsor
Right to Care
Start
May 2017
Countries
2
01

Overview

Randomised, open-label trial in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Right to Care. Primary endpoint: Retention in care. Started May 2017; status: recruiting.

02

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on PACTR201706002336105.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201706002336105.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call